{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:13:07Z","timestamp":1789985587972,"version":"4.0.1"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/2229-5178.146165","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T02:23:59Z","timestamp":1417659839000},"page":"76","source":"Crossref","is-referenced-by-count":70,"title":["Cutaneous adverse drug reactions in Indian population: A systematic review"],"prefix":"10.4103","volume":"5","author":[{"given":"TejasK","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SejalH","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DC","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.146165-1","first-page":"203","volume-title":"Severe cutaneous adverse reactions to drugs (SCAR): De\ufb01nitions, diagnostic criteria, genetic predisposition","author":"Roujeau","year":"2009","journal-title":"Dermatol Sin"},{"key":"key-10.4103\/2229-5178.146165-2","first-page":"642","volume-title":"Epidemiological study of severe cutaneous adverse drug reactions in a city district of China","author":"Li","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.146165-3","first-page":"834","volume-title":"Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","author":"Ding","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.146165-4","first-page":"734","volume-title":"An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","author":"Choon","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-5","first-page":"81","volume-title":"Prevalence of cutaneous adverse drug reactions in Southwest China: An 11-year retrospective survey on in-patients of a dermatology ward","author":"Zhong","year":"2012","journal-title":"Dermatitis"},{"key":"key-10.4103\/2229-5178.146165-6","first-page":"95","volume-title":"Cutaneous adverse drug reactions: Clinical pattern and causative agents - A 6 year series from Chandigarh, India","author":"Sharma","year":"2001","journal-title":"J Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3859","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-7","first-page":"767","volume-title":"Cutaneous adverse drug reactions in hospitalised patients","author":"Lee","year":"2010","journal-title":"Singapore Med J"},{"key":"key-10.4103\/2229-5178.146165-8","first-page":"344","volume-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","author":"von","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"key-10.4103\/2229-5178.146165-9","first-page":"805","volume-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"key-10.4103\/2229-5178.146165-10","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/2229-5178.146165-11","doi-asserted-by":"crossref","unstructured":"Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979;242:623-32.","DOI":"10.1001\/jama.1979.03300070019017"},{"key":"key-10.4103\/2229-5178.146165-12","first-page":"75","volume-title":"Pharmacovigilance study of adverse cutaneous drug reactions in a tertiary care hospital","author":"Acharya","year":"2013","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"key-10.4103\/2229-5178.146165-13","first-page":"129","volume-title":"Clinical study of adverse cutaneous drug reactions at a rural based tertiary care centre in Gujarat","author":"Anjaneyan","year":"2013","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"key-10.4103\/2229-5178.146165-14","first-page":"1","volume-title":"Adversecutaneous drug reactions: A one year survey at dermatology outpatient clinic in a tertiary care hospital","author":"Brahma","year":"2012","journal-title":"Int J Pharm World Res"},{"key":"key-10.4103\/2229-5178.146165-15","first-page":"429","volume-title":"Adverse cutaneous drug reactions: A one year survey at a dermatology outpatient clinic of a tertiary care hospital","author":"Chatterjee","year":"2006","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-16","first-page":"194","volume-title":"A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India","author":"Chattopadhyay","year":"2012","journal-title":"Niger J Clin Pract","ISSN":"https:\/\/id.crossref.org\/issn\/1119-3077","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-17","first-page":"212","volume-title":"Study and evaluation of the various cutaneous adverse drug reactions in Kasturba Hospital, Manipal","author":"Ghosh","year":"2006","journal-title":"Indian J Pharm Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0250-474X","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-18","first-page":"18","volume-title":"Evaluation of cutaneous drug reactions in patients visiting out patient Departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur","author":"Hiware","year":"2013","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-19","first-page":"1688","volume-title":"Pharmacovigilance of the cutaneous drug reactions in outpatients of dermatology department at a tertiary care hospital","author":"Inbaraj","year":"2012","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/2229-5178.146165-20","first-page":"17","volume-title":"Cutaneous adverse drug reactions in a South Indian tertiary care center","author":"James","year":"2005","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-21","first-page":"14","volume-title":"Cutaneous adverse reactions in in-patients in a tertiary care hospital","author":"Jhaj","year":"1999","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-22","first-page":"96","volume-title":"Adverse cutaneous drug reactions in a tertiary care center patients: A prospective analysis","author":"Mahapatra","year":"2012","journal-title":"J App Pharm Sci"},{"key":"key-10.4103\/2229-5178.146165-23","first-page":"50","volume-title":"Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective","author":"Nandha","year":"2011","journal-title":"Int J Appl Basic Med Res"},{"key":"key-10.4103\/2229-5178.146165-24","first-page":"292","volume-title":"Cutaneous adverse drug reactions in hospitalized patients in a tertiary care center","author":"Noel","year":"2004","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-25","first-page":"430","volume-title":"Clinical study of cutaneous drug eruptions in 200 patients","author":"Patel","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-26","first-page":"20","volume-title":"Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care center in South India","author":"Pudukadan","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-27","first-page":"792","volume-title":"Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India","author":"Saha","year":"2012","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-28","first-page":"44","volume-title":"A prospective study of cutaneous adverse drug reactions in a tertiary care hospital","author":"Vijendra","year":"2012","journal-title":"Natl J Basic Med Sci"},{"key":"key-10.4103\/2229-5178.146165-29","first-page":"839","volume-title":"Cutaneous reactions to drugs.An analysis of spontaneous reports in four Italian regions","author":"Naldi","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/2229-5178.146165-30","first-page":"770","volume-title":"Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit","author":"Campos-Fern\u00e1ndez","year":"2005","journal-title":"Rev Invest Clin"},{"key":"key-10.4103\/2229-5178.146165-31","first-page":"523","volume-title":"Cutaneous adverse drug reactions seen at a university hospital department of dermatology","author":"Borch","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2229-5178.146165-32","unstructured":"Census of India: Age structure and marital status. Available from: http:\/\/www.censusindia.gov.in\/Census-And-You\/age-structure-and-marital-status.aspx. [Last accessed on 2013 Jul 18]."},{"key":"key-10.4103\/2229-5178.146165-33","first-page":"765","volume-title":"Rates of cutaneous reactions to drugs","author":"Bigby","year":"2001","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.146165-34","first-page":"16","volume-title":"Prevalence of cutaneous drug eruption in hospitalized patients: A report from Sina Hospital of Tabriz","author":"Jelvehgari","year":"2009","journal-title":"Iran J Dermatol"},{"key":"key-10.4103\/2229-5178.146165-35","first-page":"194","volume-title":"Drug eruptions: An 8-year study including 106 inpatients at a dermatology clinic in Turkey","author":"Akpinar","year":"2012","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-36","first-page":"1018","volume-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","author":"Fiszenson-Albala","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.146165-37","first-page":"21","volume-title":"Epidemiological study of cutaneous adverse drug reactions in Oman","author":"Al-Raaie","year":"2008","journal-title":"Oman Med J"},{"key":"key-10.4103\/2229-5178.146165-38","unstructured":"Census of India: Gender composition. Available from: http:\/\/www.censusindia.gov.in\/Census-And-You\/gender-composition.aspx. [Last accessed on 2013 Jul 18]."},{"key":"key-10.4103\/2229-5178.146165-39","first-page":"747","volume-title":"Drug eruptions in Bangkok: A 1-year study at Ramathibodi Hospital","author":"Puavilai","year":"1998","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.146165-40","first-page":"227","volume-title":"Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica","author":"East-Innis","year":"2009","journal-title":"West Indian Med J"},{"key":"key-10.4103\/2229-5178.146165-41","first-page":"461","volume-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","author":"Brahimi","year":"2010","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2229-5178.146165-42","first-page":"595","volume-title":"Oral drug provocation test to generate a list of safe drugs: Experience with 100 patients","author":"Ramam","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-43","first-page":"382","volume-title":"Patient-reported multiple drug reactions: Clinical profile and results of challenge testing","author":"Ramam","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-44","first-page":"703","volume-title":"Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: A case report","author":"Sanmukhani","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/2229-5178.146165-45","first-page":"106","volume-title":"Cross-reactivity of beta-lactam antibiotics","author":"James","year":"2001","journal-title":"Proc Bayl Univ Med Cents"},{"key":"key-10.4103\/2229-5178.146165-46","first-page":"41","volume-title":"Sulfonamide allergy and cross-reactivity","author":"Brackett","year":"2007","journal-title":"Curr Allergy Asthma Rep"},{"key":"key-10.4103\/2229-5178.146165-47","first-page":"389","volume-title":"A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population","author":"Patel","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-48","first-page":"59","volume-title":"T cell-mediated hypersensitivity to quinolones: Mechanisms and cross-reactivity","author":"Schmid","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"key-10.4103\/2229-5178.146165-49","first-page":"187","volume-title":"Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction","author":"Anovadiya","year":"2011","journal-title":"J Pharmacol Pharmacother","ISSN":"https:\/\/id.crossref.org\/issn\/0976-500X","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-50","first-page":"357","volume-title":"Cutaneous drug reactions","author":"Svensson","year":"2001","journal-title":"Pharmacol Rev"},{"key":"key-10.4103\/2229-5178.146165-51","first-page":"49","volume-title":"Study of NAT2 gene polymorphisms in an Indian population: Association with plasma isoniazid concentration in a cohort of tuberculosis patients","author":"Singh","year":"2009","journal-title":"Mol Diagn Ther"},{"key":"key-10.4103\/2229-5178.146165-52","first-page":"99","volume-title":"Adverse drug reactions related to the use of non-steroidal anti-inflammatory drugs: Results of spontaneous reporting from central India","author":"Shrivastava","year":"2013","journal-title":"J Indian Med Assoc","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5847","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-53","first-page":"1160","volume-title":"Cutaneous reactions to non-steroidal anti-inflammatory drugs","author":"Kasemsarn","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/2229-5178.146165-54","first-page":"599","volume-title":"NSAID-induced urticaria and angioedema: A reappraisal of its clinical management","author":"S\u00e1nchez-Borges","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/2229-5178.146165-55","first-page":"35","volume-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs.The EuroSCAR-study","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.146165-56","first-page":"69","volume-title":"Drug induced hypersensitivity and the HLA complex","author":"Alfirevic","year":"2011","journal-title":"Pharmaceuticals"},{"key":"key-10.4103\/2229-5178.146165-57","first-page":"1134","volume-title":"HLA-AFNx013101 and carbamazepine-induced hypersensitivity reactions in Europeans","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.146165-58","first-page":"562","volume-title":"Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population","author":"Wang","year":"2010","journal-title":"Seizure"},{"key":"key-10.4103\/2229-5178.146165-59","first-page":"349","volume-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"key-10.4103\/2229-5178.146165-60","first-page":"179","volume-title":"Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital","author":"Yeung","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2229-5178.146165-61","unstructured":"Dean L. Allopurinol therapy and HLA-BFNx015801 genotype. In: Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2012. [2013 Mar 26]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK127547\/. [Last accessed on 2013 Jul 18]."},{"key":"key-10.4103\/2229-5178.146165-62","first-page":"506","volume-title":"Clinical characteristics of patients with drug hypersensitivity in Norway: A single-centre study","author":"Chalabianloo","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/2229-5178.146165-63","first-page":"39","volume-title":"Incidence, clinical features and management of acute allergic reactions: The experience of a single, Italian Emergency Department","author":"Lauritano","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key-10.4103\/2229-5178.146165-64","first-page":"171","volume-title":"Life-threatening acute adverse cutaneous drug reactions","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.146165-65","first-page":"323","volume-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.146165-66","first-page":"169","volume-title":"Agreement of expert judgment in causality assessment of adverse drug reactions","author":"Arimone","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/2229-5178.146165-67","first-page":"21","volume-title":"Methods for causality assessment of adverse drug reactions: A systematic review","author":"Agbabiaka","year":"2008","journal-title":"Drug Saf"},{"key":"key-10.4103\/2229-5178.146165-68","first-page":"1422","volume-title":"Drug-related illness in emergency department patients","author":"Dennehy","year":"1996","journal-title":"Am J Health Syst Pharm"},{"key":"key-10.4103\/2229-5178.146165-69","first-page":"538","volume-title":"Focusing on the preventability of adverse drug reactions","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"key":"key-10.4103\/2229-5178.146165-70","unstructured":"National Policy for Containment of Antimicrobial Resistance India, 2011. Available from: http:\/\/www.nicd.nic.in\/ab-policy.pdf. [Last accessed on 2013 Jul 18]."},{"key":"key-10.4103\/2229-5178.146165-71","first-page":"62","volume-title":"A study of non-prescription usage of antibiotics in the upper respiratory tract infections in the urban population","author":"Bhanwra","year":"2013","journal-title":"J Pharmacol Pharmacother","ISSN":"https:\/\/id.crossref.org\/issn\/0976-500X","issn-type":"print"},{"key":"key-10.4103\/2229-5178.146165-72","first-page":"268","volume-title":"Profile of antibiotic consumption, sensitivity and resistance in an urban area of Andhra Pradesh, India","author":"Peripi","year":"2012","journal-title":"Singapore Med J"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:25Z","timestamp":1786649665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-5178.146165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"alternative-id":["146165"],"URL":"https:\/\/doi.org\/10.4103\/2229-5178.146165","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}